Advertisement News Archives - Page 1182 of 5232 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

August 14, 2026

BMS secures FDA accelerated approval for Zenbexus in multiple myeloma

The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.

BMS secures FDA accelerated approval for Zenbexus in multiple myeloma